EnteroBiotix
PrivateLast Round
Seed Round
Apr 9, 2026
Total Funding Raised
$59.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
EnteroBiotix is a biotechnology company that develops microbiome-modulating drugs aimed at restoring health and preventing bacterial infections through tailored high-diversity microbial therapeutics for patients with serious unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EnteroBiotix Comparables
Compare EnteroBiotix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Microbiotica | 85% | |
| BiomeBank | 83% | |
| Human Biome S.A. | 82% | |
EnteroBiotix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 9, 2026 | ||||
| Series B | Apr 4, 2024 | ||||
| Series A | Sep 7, 2021 | ||||
| Seed | May 29, 2019 | ||||
| Seed | Jun 21, 2017 | ||||
Grant | Jun 21, 2017 |
Key People
Founding team and executive leadership
EnteroBiotix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Aberdeen | Seed |
| Gabriel Investments Ltd | Seed |
| Kineticos Ventures | Series A, Series B |
| Equity Gap | Series B, Seed |
| Scottish EDGE | Grant |
| Scottish National Investment Bank | Seed, Series A, Series B, Seed Round |
| Barwell Plc | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Lead candidate EBX-102-02 advances to Phase 2b for IBS-C treatment.
- Apr 9, 2026
Raised $5.3M in a Seed Round.
EnteroBiotix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EnteroBiotix's valuation, stock price, and market status.